| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1224188B1 Nasal delivery composition comprising the methane sulphonate salt of morphine and chitosan |
| 01/17/2007 | CN1898370A Fat composition |
| 01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
| 01/17/2007 | CN1898217A Benzo'1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 01/17/2007 | CN1898203A Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 01/17/2007 | CN1898201A Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 01/17/2007 | CN1897977A In vivo gene therapy of parkinson's disease |
| 01/17/2007 | CN1897955A Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 01/17/2007 | CN1897953A Anti-inflammatory agents |
| 01/17/2007 | CN1897938A Use of 1,3-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/17/2007 | CN1897935A Use of rotigotine for treatment or prevention of dopaminergic neurone loss |
| 01/17/2007 | CN1897934A Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896098A Buthotoxin polypeptide and its use |
| 01/17/2007 | CN1896084A Non-sedating barbituric acid derivatives |
| 01/17/2007 | CN1896076A Tricyclic-type compound, and medicine having it as effective component |
| 01/17/2007 | CN1896073A New phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/17/2007 | CN1896063A Stabilized high-melt-point alipizo crystal and its preparation |
| 01/17/2007 | CN1896062A New phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/17/2007 | CN1895670A Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 01/17/2007 | CN1895654A Sobering-up pills |
| 01/17/2007 | CN1895645A Chinese for drug abstinence and its preparation |
| 01/17/2007 | CN1895617A Kidney-warming and heart-nourishing Chinese-medicinal preparation, its making method and quality control |
| 01/17/2007 | CN1895615A Electruary for treating hyposomnia |
| 01/17/2007 | CN1895614A Chinese-medicinal preparation for treating hyposomnia |
| 01/17/2007 | CN1895611A Sobering-up tea |
| 01/17/2007 | CN1895590A Antong beverage |
| 01/17/2007 | CN1895583A Cold-dispelling beverage |
| 01/17/2007 | CN1895567A Tall gastrodia tube and glossy ganoderma preparation and its making method |
| 01/17/2007 | CN1895566A Medicinal composition for treating wind cold and rheumatic headache |
| 01/17/2007 | CN1895562A Decoction for treating exuberance of heart-liver fire depressive disorders and its preparation |
| 01/17/2007 | CN1895561A Decoction for treating insufficiency of both heart and spleen depressive disorders and its preparation |
| 01/17/2007 | CN1895539A Antong electruary |
| 01/17/2007 | CN1895532A Sunshine beverage |
| 01/17/2007 | CN1895483A Stomach-nourishing beverage |
| 01/17/2007 | CN1895477A Antidespressant and its preparation |
| 01/17/2007 | CN1895472A Chinese medicine for treating dementia praecox |
| 01/17/2007 | CN1895448A Hawthorn fruit and lotus chrysanthemum flower electruary |
| 01/17/2007 | CN1895438A Chinese-medicinal composition for treating cephalagia and its preparation |
| 01/17/2007 | CN1895415A Skin-softening electuary |
| 01/17/2007 | CN1895408A Radix saposhnikoviae Tong Sheng capsules, preparation and quality control thereof |
| 01/17/2007 | CN1895387A Chinese medicine for treating mental retardation, tranquilization and promotion of growth |
| 01/17/2007 | CN1895341A Chinese-medicinal preparation for treating cardiovascular and cerebrovascular diseases |
| 01/17/2007 | CN1895340A Sobering-up composition |
| 01/17/2007 | CN1895334A Health-care medicine against brain fatigue |
| 01/17/2007 | CN1895313A Extraction of total saponin from ginseng or American ginseng stem/leaf and its product |
| 01/17/2007 | CN1895310A Extracts of yellow rhizoma ligustici and preparing method and use thereof |
| 01/17/2007 | CN1895294A Chinese pilose spore concentrated oral liquid |
| 01/17/2007 | CN1895275A Calf-blood deprotein extract gel |
| 01/17/2007 | CN1895274A Calf-blood deprotein capsules and preparation thereof |
| 01/17/2007 | CN1895256A Use of 20(S)-protopanoxadiol in preparation of antidepressant medicine |
| 01/17/2007 | CN1895252A Zirasitone mesylate soluble medicinal preparation |
| 01/17/2007 | CN1895251A Stabilized nalmefene hydrochloride injection and its preparation |
| 01/17/2007 | CN1295332C Recombinant human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295217C New asymmetric diaryl-methylamine intermediates for the preparation of diarylmethylpiperazines derivatives |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/17/2007 | CN1294983C Medicine for treating facial paralysis and its preparing method |
| 01/17/2007 | CN1294975C Medicine for alleviating pain of cancer |
| 01/17/2007 | CN1294970C Traditional Chinese medicine capsule for treating insomnia and method for preparing same |
| 01/17/2007 | CN1294968C Chinese herbal medicine capsule for treating epilepsia |
| 01/17/2007 | CN1294962C Beautifying sleep-improving health tea |
| 01/17/2007 | CN1294950C Sobering up tea powder |
| 01/17/2007 | CN1294917C Injection for curing italitai disease |
| 01/17/2007 | CN1294914C Chinese medicinal injection liquid for giving up drug |
| 01/17/2007 | CN1294909C Novel anti-biological cell free-radical oxidation injury mixture |
| 01/17/2007 | CN1294901C Embolism eliminatinging drop pills with qi invigorating, blood flow promoting and collateral dredging function |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164024 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 01/16/2007 | US7164021 Intensify therapy of analgesics; immunology diseases; antiinflammatory agents; drug abuse; diarrhea; cardiovascular disorders; antisecretory agents; respiratory system disorders |
| 01/16/2007 | US7163960 Treatment and prevention of inflammatory disorders |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163957 anti-psychotic; selectively interact with the dopaminergic receptors of the D2/D3 subtypes and the serotoninergic receptors of the 5-HT1A subtype at the level of which they behave as antagonists and agonists, respectively |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163949 for the treatment of various neurological and psychological disorders; compounds which block reuptake of norephinephrine, dopamine, and serotonin with particular selectivity ratios; reduced side effect profile |
| 01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 01/16/2007 | US7163929 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/16/2007 | US7163922 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 01/16/2007 | US7163921 Peptide derivatives and medicinal compositions |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163689 Administering intravenous valproate such that acute migraine headache is lessened or reduced in subject, wherein about 250 mg to 750 mg of valproate is administered to a subject over 30 minutes to 1 hour |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | CA2326662C Therapeutic system which can be moisture-activated |
| 01/16/2007 | CA2254755C Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 01/16/2007 | CA2253453C Alkylaminobenzothiazole and -benzoxazole derivatives |
| 01/16/2007 | CA2174449C R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 01/11/2007 | WO2007005510A1 N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| 01/11/2007 | WO2007005503A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | WO2007005404A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 01/11/2007 | WO2007005366A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION |
| 01/11/2007 | WO2007005174A2 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 01/11/2007 | WO2007004960A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer’s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson’s disease |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004689A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 01/11/2007 | WO2007004685A2 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007004523A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 01/11/2007 | WO2007004510A1 Pharmaceutical for use in the treatment of cerebral infarction |